K-pop

TXT’s Yeonjun, on a “solo run,” shows his true potential in Japan… Tops the Oricon Charts

Release of Second Mini-Album No. 1 on the Daily Album Chart

KIM HYUNSIK
2026-07-15 11:38:40
[Edaily Starin KIM HYUNSIK Reporter] Yeonjun of the boy group Tomorrow X Together (TXT) has topped the Japanese Oricon charts with his new solo album.
(Photo courtesy of Big Hit Music)
According to his agency, Big Hit Music, on the 15th, Yeonjun’s second mini-album, “NO LABELS: PART 02,” went straight to No. 1 on the Oricon Daily Album Ranking on the 13th, the day of its release. Previously, Yeonjun’s first mini-album, “NO LABELS: PART 01,” released last November, also topped the same chart.
“NO LABELS: PART 02” is an album consisting of six tracks in total, including the title track “Ice Cream.” Yeonjun personally participated in choreographing the title track and is credited as a lyricist for the tracks “Baby Wassup?” and “Long Way Long Ride.”
According to Hanteo Chart, a South Korean album sales tracking site, this album sold over 660,000 copies on its release day alone. This marks the highest first-day sales figure among solo artist albums released this year. Yeonjun surpassed the first-week sales of his previous album in just one day, achieving a career high.
Next month, Yeon Jun will take the stage at the “Summer Concert Series,” hosted by ABC’s flagship morning news program “Good Morning America,” and at the “Z100 Summer Bash Presented by Wells Fargo,” organized by Z100, a radio station under iHeartMedia.

Economy

Corporation

IT·Science

Economy

[Market In] Far Exceeding the Target Amount by 10 Times… 2.1 Trillion Won in “Lump-Sum Funds” Flows into NH INVESTMENT & SECURITIES Corporate Bonds

NH INVESTMENT & SECURITIES(005940)The company successfully secured its target issuance amount by raising funds exceeding 10 times the target amount during the bookbuilding process for its corporate bo…
2026-09-08 18:00:03

Corporation

Neopharm CO., LTD., on a "Record-Breaking Streak of Earnings," Expands into a Global Derma-Beauty Brand

Neopharm CO., LTD.(092730), a South Korean derma-beauty specialist, is seeking to expand into a global derma-beauty brand by leveraging “Atopam,” a skincare brand specializing in sensitive skin condit…
2026-09-08 17:48:06

IT·Science

“Korea’s 44th Domestically Developed New Drug,” Latica, Launched… Taking on the 500 Billion Won Dry Eye Market

(Graphic: ChatGPT) A domestically developed treatment with a new mechanism of action is set to enter the Korean dry eye market, which has long been dominated by artificial tears. This follows the …
2026-09-08 17:11:02